MiniMed Inc. (MMED) highlighted its robust growth trajectory at the Bank of America Global Healthcare Conference, emphasizing a 12-quarter streak of high single-digit to low double-digit revenue growth. The company’s U.S. unit growth surged past 20% in the first quarter, driven by the launch of the Simplera Sync sensor paired with its Flex durable pump—a first major hardware and software refresh in over a decade. The Flex pump, designed for type 2 diabetes patients requiring higher insulin needs, features a 300-unit reservoir, marking a significant upgrade from prior models. Notably, only five weeks of the quarter were impacted by the launch, excluding the Instinct CGM from Abbott, which entered the market last month.
MiniMed Reports U.S. Growth of 20% as It Accelerates Durable Pump and CGM Expansion
CEO and CFO highlight strategic investments in hardware refreshes, international expansion, and next-generation closed-loop technology to drive long-term profitability and market share.
SL
Sophie Laurent · FX & Rates Desk · 23 Sept 2026 · 12:37 · 1 Min. Lesezeit
Dieser Artikel wurde mit KI-Unterstützung erstellt und von einer Finances-Review-Redakteurin bearbeitet.
ADVERTISEMENT
SL
Geschrieben von
Sophie Laurent
FX & Rates Desk
Sophie covers currency markets and central bank policy across Europe, with a focus on how rate decisions ripple through FX pairs. She has been tracking the ECB's policy path since the start of the current easing cycle.
Mehr von Sophie Laurent →
